Glycogenin 1 Antikörper (AA 251-350)

Produktnummer ABIN1714552

Produktdetails anti-Glycogenin 1 Antikörper

Target: Glycogenin 1 (GYG1)

Bindungsspezifität: AA 251-350

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Glycogenin 1 Antikörper ist unkonjugiert

Applikation: Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunocytochemistry (ICC)

Homologie: Human,Mouse,Rat,Dog,Cow,Sheep

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human Glycogenin 1

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Details zu Glycogenin 1

Target: Glycogenin 1 (GYG1)

Andere Bezeichnung: Glycogenin 1 (GYG1 Produkte)

Synonyme: GSD15 antikoerper, GYG antikoerper, Gyg antikoerper, gyg antikoerper, fc13d04 antikoerper, fi23f07 antikoerper, gyg1 antikoerper, wu:fc13d04 antikoerper, wu:fi23f07 antikoerper, zgc:55385 antikoerper, zgc:85619 antikoerper, glycogenin-1 antikoerper, MGC79098 antikoerper, GYG1 antikoerper, glycogenin 1 antikoerper, glycogenin 1a antikoerper, glycogenin 1 S homeolog antikoerper, GYG1 antikoerper, Gyg1 antikoerper, gyg1 antikoerper, gyg1a antikoerper, gyg1.S antikoerper

Hintergrund:

Synonyms: Glycogenin, Glycogenin-1, Glycogenin1, GLYG_HUMAN, GN-1, GN1, GYG 1, GYG, GYG1.

Background: Glycogen synthesis is initiated by the autoglucosylation of Glycogenin-1. Specifically, Glycogenin-1 glucosylates itself to begin the synthesis of glycogen in mammalian skeletal muscle. It acts as the primer to which further glucose monomers may be added. All of the Glycogenin-1 Molecules contain at least one glucosyl residue before autoglucosylation begins. The first step of the glycogen synthesis occurs when a glucose molecule from UDP-glucose binds to the hydroxyl group of Tyr 194 on the Glycogenin-1 Molecule. Using its glucosyltransferase activity, Glycogenin-1 adds more glucoses, each one coming from UDP-glucose. The glycosylation process reaches a plateau when five new glucose residues have been added, at which point glycogen synthase (GS) takes over and further elongates the chain. Glycogenin-1 remains covalently attached to the reducing end of the glycogen molecule.

Pathways: Cellular Glucan Metabolic Process